Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction
Marine Drugs · 2026
DOI: 10.3390/md24010043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Meiting Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, College of Life Science and Technology, Guangxi University, Nanning 530004, China. Hauptthemen laut MEDLINE: Conotoxins, Hippocampus, Tobacco Use Disorder, Nicotinic Antagonists. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sulan Luo, Dongting Zhangsun, NIGMS NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Nicotine is the main substance responsible for the development of tobacco addiction. The α3β4 nicotinic acetylcholine receptors (nAChRs) are a potential key target for mitigating nicotine reward. Preliminary studies in our laboratory suggest that α-conotoxin [S9K]TxID serves as a selective and potent antagonist targeting α3β4 nAChRs, which may be beneficial in addressing nicotine addiction. However, the mechanisms of [S9K]TxID treatment in nicotine addiction are still to be determined. This study aimed to identify the differential metabolic profiles of [S9K]TxID treatment in nicotine addiction using an untargeted metabolomic profiling method. As demonstrated by behavioral experiments, [S9K]TxID effectively attenuated nicotine-induced conditioned place preference (CPP) expression without exerting inhibitory effects on the central nervous system (CNS). The results of untargeted metabolomics revealed that eight metabolites were significantly altered after [S9K]TxID treatment, particularly phenylalanine. [S9K]TxID also attenuated nicotine-induced metabolic disorders by regulating phenylalanine, tyrosine and tryptophan biosynthesis. In conclusion, our findings suggest that [S9K]TxID could be a potential therapeutic compound for nicotine addiction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Special Biomedicine, School of Medicine, College of Life Science and Technology, Guangxi University, Nanning 530004, China.
- Key Laboratory of Tropical Biological Resources of Ministry of Education, Hainan University, Haikou 570228, China.
- Departments of Biology and Psychiatry, University of Utah, Salt Lake City, UT 84112, USA.
- George E. Wahlen Veterans Affairs Medical Center, Salt Lake City, UT 84108, USA.
ORCID-Profile: Jinpeng Yu, Sulan Luo
Förderung
- Sulan Luo
- Dongting Zhangsun
- NIGMS NIH HHS
- Major International Joint Research Project of National Natural Science Foundation of China
- Key Project of Natural Science Foundation of Guangxi
- National Natural Science Foundation of China
- “Dai Tu Yi Zhi” Project of Key R & D Program of Guangxi
- Major Intergovernmental Joint Research Project of National Key R & D Program of China
Zitieren
APA
Wang, M., Xu, W., Wang, H., Cui, C., He, R., Li, X., Yu, J., McIntosh, J. M., Zhangsun, D., & Luo, S. (2026). Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction. Marine Drugs. https://doi.org/10.3390/md24010043
Vancouver
Wang M, Xu W, Wang H, Cui C, He R, Li X, et al. Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction. Marine Drugs. 2026. doi:10.3390/md24010043
BibTeX
@article{Wang2026,
author = {Wang, Meiting and Xu, Weifeng and Wang, Huanbai and Cui, Cheng and He, Rongyan and Li, Xiaodan and Yu, Jinpeng and McIntosh, J Michael and Zhangsun, Dongting and Luo, Sulan},
title = {Hippocampal Metabolomics Reveal the Mechanism of α-Conotoxin [S9K]TxID Attenuating Nicotine Addiction},
journal = {Marine Drugs},
year = {2026},
doi = {10.3390/md24010043}
}
EUVIMED